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Abstract: African trypanosomes cause devastating disease in sub-Saharan Africa in humans and
livestock. The parasite lives extracellularly within the bloodstream of mammalian hosts and is
transmitted by blood-feeding tsetse flies. In the blood, trypanosomes exhibit two developmental
forms: the slender form and the stumpy form. The slender form proliferates in the bloodstream,
establishes the parasite numbers and avoids host immunity through antigenic variation. The stumpy
form, in contrast, is non-proliferative and is adapted for transmission. Here, we overview the features
of slender and stumpy form parasites in terms of their cytological and molecular characteristics
and discuss how these contribute to their distinct biological functions. Thereafter, we describe
the technical developments that have enabled recent discoveries that uncover how the slender to
stumpy transition is enacted in molecular terms. Finally, we highlight new understanding of how
control of the balance between slender and stumpy form parasites interfaces with other components
of the infection dynamic of trypanosomes in their mammalian hosts. This interplay between the
host environment and the parasite’s developmental biology may expose new vulnerabilities to
therapeutic attack or reveal where drug control may be thwarted by the biological complexity of the
parasite’s lifestyle.
Keywords: Trypanosoma brucei; transmission; stumpy form; differentiation; life-cycle; quorum sensing
1. Introduction
Persistence in regularly changing environments demands that vector-transmitted pathogens
rapidly adapt to fluctuating conditions. Trypanosoma brucei, similar to many eukaryotic parasites,
encounters different environments as it transitions between its mammalian host and the tsetse fly
vector, Glossina spp. In these different environments, distinct T. brucei life cycle forms, specialised for
the various niches encountered, have evolved to optimise parasite survival and to ensure transmission
to the next host (Figure 1).
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Figure 1. The changing environments of the T. brucei life cycle. (1) Following a tsetse fly blood meal 
on an infected mammal (blue arrow), T. brucei stumpy cells reaching the tsetse midgut differentiate 
to procyclic cells. (2) Development of T. brucei proceeds through the tsetse midgut to the 
proventriculus. (3) Differentiation to epimastigote cells is followed by production of 
mammalian-infective metacyclic cells in the salivary gland. (4) On transfer to a new mammalian host 
via a tsetse fly bite (blue arrow), metacyclic cells differentiate to bloodstream forms. (5) In the 
bloodstream, proliferative slender cells elevate the parasitaemia until accumulation of a 
density-dependent signal triggers differentiation to the cell-cycle arrested stumpy form (via an 
intermediate stage). The stumpy form of T. brucei faces a particular challenge in that it must survive 
long enough in the bloodstream to be transmitted, but it must also survive long enough in the tsetse 
midgut to differentiate to the next life cycle stage and establish infection. These different 
environments pose different challenges that must be overcome to enable the continuation of the 
parasite life cycle. For example, in the mammalian host (red section), parasites must evade immune 
attack to ensure parasite survival and avoid excessive exploitation of host resources to ensure the 
host survives long enough to enable successful transmission to the tsetse fly vector. On uptake to the 
tsetse fly midgut (orange section), the parasites face a shift in nutrient availability and temperature 
among other challenges. For a review of factors effecting establishment of tsetse fly midgut infection 
see [1]. 
The challenges presented by the distinct environments encountered during the life cycle differ. 
In the mammalian bloodstream, for example, the parasite must face a host immune response that is 
constantly trying to control the infection. To evade this control and to thrive extracellularly within 
the mammalian host bloodstream, trypanosomes have evolved the extraordinary capacity to 
overcome a barrage of host innate and adaptive immunological defences via the expression, and 
switching, of their expressed Variant Surface Glycoprotein (VSG) coat, a process termed antigenic 
variation [2]. The periodic destruction of antigenic variants, followed by the outgrowth of 
antigenically distinct variants, contributes to the undulating waves of parasitaemia typical of 
trypanosome infection. 
Within each of these cyclical waves, a density-dependent developmental switch represents 
another important evolutionary adaptation, both regulating parasite virulence and pre-adapting the 
parasite for uptake by the tsetse fly. Infections are maintained in the host bloodstream by rapidly 
proliferating morphologically “slender” cells. Allowed to replicate unchecked, slender parasites 
would rapidly kill the host [3]. Consequently, it is important that parasites regulate their growth in 
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Figure 1. The changing environments of the T. brucei life cycle. (1) Following a tsetse fly blood meal
on an infected mammal (blue arrow), T. brucei stumpy cells reaching the tsetse midgut differentiate to
procyclic cells. (2) Development of T. brucei proceeds through the tsetse midgut to the proventriculus.
(3) Differentiation to epimastigote cells is followed by production of mammalian-infective metacyclic
cells in the salivary g and. (4) On transfer to a new mammal n h st via a tsetse fly bite (blue arrow),
metacyclic cells differentiate to bloodstream forms. (5) In the bloodstream, proliferative slender cells
elevate the parasitaemia until accumulation of a density-dependent signal triggers differentiation to
the cell-cycle arrested stumpy form (via an intermediate stage). The stumpy form of T. brucei faces
a particular challenge in th t it must survive long enough in the loodstream to be transmitted, but
it must also survive long enough in th tsetse midgut t differ ntiate to e next life cycle stage and
establish infection. These different environments pose different challenges that must be overcome to
enable the continuation of the parasite life cycle. For example, in the mammalian host (red section),
parasites must evade immune attack to ensure parasite survival and avoid excessive exploitation of
host resources to ensure the host sur ives long enough to enable succes ful transmission to the tsetse
fly vector. On uptake to the tsetse fly midgut (orange section), the parasites face a shift in nutrient
availability and temperature among other challenges. For a review of factors effecting establishment of
tsetse fly midgut infection see [1].
The challenges presented by the distinct environments encountered during the life cycle differ.
In the mammalian bloodstream, for example, the parasite must face a host immune response that is
constantly trying to control the infection. To evade this control and to thrive extracellularly within the
mammali host bloodstream, trypanosom s have evolved the extra rdin ry capacity to vercome
a barrage of host innate and adaptive immunological defences via the expression, and switching, of
their expressed Variant Surface Glycoprotein (VSG) coat, a process termed antigenic variation [2].
The periodic destruction of antigenic variants, followed by the outgrowth of antigenically distinct
variants, contributes to the undulating waves of parasitaemia typical of trypanosome infection.
Within each of these cyclical wav s, a density-dependent dev lopmental switch represents
another important evolutionary adaptation, both regulating parasite virulence and pre-adapting
the parasite for uptake by the tsetse fly. Infections are maintained in the host bloodstream by rapidly
proliferating morphologically “slender” cells. Allowed to replicate unchecked, slender parasites would
rapidly kill the host [3]. Consequently, it is important that parasites regulate their growth in vivo to
promote longevity of the host and maximize their transmission potential [4,5]. Such regulation is
achieved by a developmental switch initiated upon reaching a critical parasite density. Specifically,
proliferative slender cells respond to the accumulation of a small soluble parasite-derived factor,
stumpy induction factor (or factors) (SIF), and differentiate to specialized cell-cycle arrested “stumpy”
Pathogens 2017, 6, 29 3 of 19
cells [6,7]. As growth-arrested stumpy cells accumulate during the ascending parasitaemia, the parasite
population growth is restricted thereby prolonging the infection and increasing the opportunity
for transmission [6–8]. Parasite strains that respond to this density-mediated growth control by
differentiating to stumpy cells are described as pleomorphic. Extensive passage of laboratory strains
can, however, select against differentiation to stumpy cells, resulting in “monomorphic” strains that
do not arrest as transmissible forms in response to parasite density [9].
Beyond its cell-cycle arrest, the stumpy form of T. brucei has characteristics that distinguish it
from the slender form, fulfilling its specialised role in transmission to the insect vector. In this review,
we begin by describing the developments in our understanding of the nature of the different forms
of T. brucei in the mammalian host, from initial morphological descriptions to detailed molecular
characterisation. Secondly, we discuss investigations into the mechanism coordinating differentiation
from slender to stumpy cells, considering how historical findings have provided tools to further
elucidate this process. Finally, we reflect on outstanding questions relating to T. brucei differentiation
and infection dynamics in the mammalian host.
2. Characterisation of Slender and Stumpy Cells
Differences in the morphology of Trypanosoma brucei spp. in the mammalian bloodstream were
recognised in the early 1900s with descriptions and drawings of slender, intermediate and stumpy
cells by Bruce [10]. These descriptions were followed by the observation that the stumpy form
was apparently the morphotype capable of establishing infection of the tsetse fly vector [11,12].
Subsequent research sought to answer why the stumpy form was able to survive in the tsetse midgut
and thus continue the parasite’s life cycle.
On uptake by the vector, parasites enter a challenging environment in the tsetse midgut.
Slender cells are killed rapidly and it is stumpy cells that survive to differentiate to the next life
cycle stage [13]. Characteristics of stumpy cells that likely contribute to their survival in the fly midgut
include their relative resistance to acidic and proteolytic stress [14]. For example, the differential
response to mild acid conditions (pH 5.5) has been used as a selection to monitor the differentiation to
stumpy cells in some studies [15], as slender cells are sensitive and stumpy cells are resistant. Moreover,
protease treatment has been shown to act as a trigger for bloodstream forms to differentiate to procyclic
cells [16–18]. Likewise, pretreatment in mild-acid conditions (pH 5.5) has been shown to stimulate
stumpy cells to differentiate to procyclic cells at 27 ◦C [19].
Different host environments also provide alternative nutritional opportunities for a parasite.
For instance, in the mammalian bloodstream T. brucei can exploit an abundant glucose supply.
On uptake by the tsetse fly, however, proline replaces glucose as the most readily available energy
source [20], and an intact proline metabolic pathway has been shown to be essential for successful
T. brucei colonisation of the tsetse midgut [21]. Correspondingly, procyclic cells inhabiting the tsetse
midgut possess a more elaborate and active mitochondrion than slender bloodstream forms [22].
In preparation for this, differentiation in the bloodstream from the slender form to the stumpy form is
accompanied by activation of the mitochondrion, as evidenced by detection of NAD diaphorase
activity and the ability of intermediate and stumpy cells to use the Krebs cycle intermediate
α-keto-glutaric acid (α-KGA) to maintain motility in the absence of glucose [23]. NADH dehydrogenase
(diaphorase) activity has remained an accepted (though qualitative and somewhat ambiguous)
marker for identifying stumpy bloodstream cells, but has more recently been superseded by the
use of mitochondrial dyes such as MitoTracker® (Molecular probesTM) [24]. A further intracellular
rearrangement occurring during the differentiation to stumpy cells is the repositioning of the lysosome.
In slender cells a single lysosome is positioned equidistant between the nucleus and kinetoplast at the
posterior end of the cell, whereas differentiation to stumpy cells is accompanied by movement of the
lysosome to the anterior side of the nucleus [25]. An additional remodelling of the endocytic system
that occurs during differentiation is the down-regulation of the haptoglobin-haemoglobin receptor in
stumpy cells [25].
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Once stumpy cells have been ingested by the tsetse fly they must be ready to perceive the signals
that trigger differentiation to the proliferative procyclic form adapted for the colonisation of the
midgut. Cold shock (i.e., a reduction from 37 ◦C to 20 ◦C) is able to sensitise stumpy (but not slender)
parasites for perception of the differentiation signals cis-aconitate and citrate [26]. A carboxylate
transporter protein family, known as Proteins Associated with Differentiation (PAD), is required for the
response to this citrate cis-aconitate differentiation signal [27]. Thus, PAD2 expression is up-regulated
at 20 ◦C and the protein is redistributed from the flagellar pocket to the parasite surface, enabling the
cold-stimulated perception of the differentiation signal. PAD1 protein, in contrast, was found to be
expressed specifically on the surface of stumpy, but not slender, bloodstream cells and is now used
extensively in differentiation studies as a molecular marker for stumpy parasites. For example, in a
study of chronic T. brucei infections in mice, intermediate and stumpy cells were found to dominate
later stages of infection [8], the relative expression of PAD1 mRNA detected by qRT-PCR being used as
a tool to reflect the transmission capacity of the population. PAD1 mRNA expression is detectable in
the intermediate cells that precede morphological transformation to stumpy cells, this being followed
by protein expression as mature stumpy cells arise, the regulatory signals governing progressive
activation having been localised in the PAD1 3′UTR [28].
Another group of proteins with strong developmental regulation are the Expression Site
Associated Gene (ESAG) 9 family [29] which are specifically expressed in stumpy, but not slender
cells. Although originally identified as components of some VSG expression sites [30], ESAG9 genes
are rare expression site (ES) components [31], being frequently found in non-expression site locations.
The function fulfilled by this family of proteins remains unclear, but they appear to be secreted by
the parasite and could therefore interact with the mammalian immune system or assist stumpy form
transmission upon entry into the fly. Regions in the 3′UTRs of ESAG9 [32] and PAD1 [28] with
involvement in the developmental regulation of these stumpy-expressed proteins have been identified.
Moreover, a cell line engineered to place expression of a reporter gene under the control of the PAD1
3′UTR has been developed as a useful tool to study differentiation from slender to stumpy cells. This
cell line was successfully used in a high-throughput screen to identify a compound able to induce
partial differentiation to stumpy cells [33], whereas a PAD1 3′UTR linked GFP reporter has also
been used in cytological studies of stumpy cells in adipose tissue [34]. Recently, knowledge of the
stumpy-specific regulation of ESAG9 was successfully applied to identify a protein that negatively
regulates the expression of stumpy-specific genes [35]. This utilised a screen exploiting a cell line
containing both a tetracycline-inducible genome-wide RNAi library [36] and a drug resistance gene
under the control of the 3′UTR of ESAG9. The screen identified REG9.1, a molecule with a predicted
RNA binding motif, whose silencing by RNAi resulted in derepression of many ESAG9 genes as well
as the mRNAs for two novel predicted cell-surface families (Family 5 and Family 7) that were also
found to be enriched in stumpy cells [35].
The most obvious distinction between slender and stumpy cells of T. brucei is that a slender
population is proliferative, whereas stumpy cells are arrested in G0/G1 of their cell cycle [37].
In addition to extending host survival, the cell cycle arrest displayed by stumpy cells contributes to
their competence for transmission. For instance, it was proposed that there was a point in the cell
cycle (G0/G1) when cells were receptive to the signal to differentiate to procyclic cells after which
they re-enter the cell cycle [38]. This co-ordination of cell cycle position and differentiation capacity
ensures that the organellar repositioning events that accompany differentiation can be achieved
without perturbation of the precisely orchestrated cytological events that accompany the parasite’s
cell division [39,40]. It also explains why uniform populations of stumpy cells already arrested at
this point of the cell cycle are able to differentiate synchronously, unlike asynchronous monomorphic
bloodstream forms [41].
The efficiency with which stumpy cells differentiate synchronously to procyclic cells in vitro
provides a useful and physiologically relevant assay to monitor the abundance of stumpy cells in a
bloodstream parasite population. This assay can be effectively performed in vitro using cis-aconitate,
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combined with a reduction in temperature from 37 ◦C to 27 ◦C, to stimulate differentiation [41–43].
The changes accompanying differentiation to procyclic cells include replacement of the VSG coat
with a procyclin surface coat [44–46], repositioning of the mitochondrial genome (the kinetoplast) [40]
and cell cycle re-entry [38,47]. Thus, the tools exist to effectively test the capacity of a population of
bloodstream trypanosomes to synchronously differentiate to procyclic cells, helping to distinguish
physiologically relevant stumpy cells from (for example) RNAi phenotypes that perturb cell shape or
proliferation and generate cells superficially similar to stumpy morphology.
Differentiation from stumpy to procyclic cells triggered by citrate/cis-aconitate or mild acid
treatment is signalled via a protein phosphorylation cascade [18]. TbPTP1, a protein tyrosine
phosphatase [48], dephosphorylates and inactivates the DxDxT class serine-threonine phosphatase
TbPIP39 (TbPTP1-interacting protein, 39kDa) [49] to prevent differentiation of stumpy cells in the
bloodstream. Once parasites reach the appropriate environment of the tsetse midgut, they perceive
the differentiation signal, TbPTP1 is inactivated and TbPIP39 is phosphorylated (and so activated)
and translocated to the glycosome. TbPIP39 mRNA is expressed at highest levels in stumpy cells.
However, while barely detectable in slender cells, TbPIP39 protein is detected in stumpy cells but
protein expression is highest in procyclic cells [49]. The expression of proteins, such as TbPIP39,
required for differentiation to the next life cycle stage is another feature of stumpy cells that prepares
them for transmission. Indeed, the detection of increased TbPIP39 transcript abundance has been used
as an indicator of the presence of stumpy cells in a bloodstream population of T. b. rhodesiense [50],
and this can supplement the use of other stumpy markers such as PAD1 expression. Likewise, the
protein kinase NRKA/B is a key regulator of differentiation when parasites enter the tsetse fly and
this molecule is exclusively expressed in stumpy cells, providing another means to identify this cell
type [51,52].
Further differences between slender and stumpy bloodstream cells have been described in how
these cells interact with the host immune system. Slender cells of T. brucei can switch their expressed
VSG to one that is antigenically distinct and outgrow as new antigenic variants. This enables survival
of a subset of switched cells when the host develops an immune response against the dominant VSG
expressed by the population ([22], and reviewed in [53]). Stumpy cells, in contrast, do not switch to
express novel VSG [54] and—being irreversibly arrested—cannot establish new variant populations.
However, stumpy cells have a higher rate of endocytosis than slender cells and are better able to
rapidly clear IgG-VSG from the cell surface to delay complement-mediated lysis [55,56]. This may
enable stumpy cells to survive for long enough to increase their probability of transmission.
T. brucei VSG expression is under strict control with transcription active from only one expression
site at a time, maintaining monoallelic VSG expression [31,57]. A link between antigenic variation
and life cycle progression was proposed when it was found that overexpression of an exogenous VSG
in monomorphic T. brucei could stimulate an accumulation of the cell population in G1 of the cell
cycle, expression of PAD1 and an enhanced ability to differentiate to procyclic cells in response to
cis-aconitate treatment [58]. This effect was mediated through repression of the active ES, and linked
to the concomitant silencing of ESAGs 1, 2 and 8 since RNAi targeting these transcripts reproduced the
phenotype. However, this effect must be distinct from the quorum-sensing mediated differentiation
from slender to stumpy cells since the phenotype caused by overexpression of the exogenous VSG was
reversible. This contrasts with density-induced slender to stumpy differentiation which is irreversible.
Encouraged by the findings in monomorphic cells, Zimmermann et al. (2017) recently tested
the hypothesis that transcriptional attenuation at the ES could elicit life cycle progression in
biologically-relevant pleomorphic cells in vitro [59]. Here, ectopic overexpression of a second VSG
generated two populations of cells with distinct growth phenotypes, either those which rapidly ceased
proliferation upon induction or those that continued to divide. The growth-arrested cells exhibited
complete transcriptional attenuation of the ES, whilst those that continued to divide did not. Moreover,
VSG overexpression-induced ES attenuation caused cells to accumulate in G1 and upregulate the
expression of stumpy-specific proteins, such as PAD1, in a density (and therefore SIF) independent
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manner. Upon exposure to cis-aconitate, cells could synchronously differentiate to procyclic cells, and
were capable of establishing mature tsetse fly infections demonstrating their physiological relevance.
Cells which remained proliferative upon overexpression of a second VSG, however, remained slender
and, though the initial VSG was silenced, the ES remained in an incompletely attenuated state.
The authors proposed that, upon switching to a new ES with defective function, the parasite may
respond in one of two ways: if the activity of the initial ES remains above a critical threshold, this state
is maintained and the parasite continues to proliferate; if, however, the ES-activity has fallen below
this threshold, the parasite differentiates to the growth-arrested stumpy form in a density-independent
manner. This mechanism was proposed to provide a potential escape for parasites that switch to an ES
insufficient to fulfil requirements in a given host environment, although the physiological relevance of
this for overall parasite transmission remains to be established.
Advances in technology have allowed global analyses of differences between life cycle forms in
terms of expressed transcripts, protein abundance and phosphorylation status. In the stumpy form,
reduced protein synthesis, possibly regulated through translation initiation [60], accompanies cell
cycle arrest [61]. Accordingly, transcripts such as histones associated with an active cell cycle, as well
as glycolytic pathway components and cytoskeletal transcripts were found to be down-regulated in
stumpy cells [62–64]. On the other hand, transcripts involved in protein synthesis were observed to be
up-regulated in procyclic cells [62]. Transcripts escaping the generalised translational repression
in stumpy cells were identified from polysomal material [61]. Thus, components of oxidative
phosphorylation and amino acid metabolism, amino acid transporters and mitochondrial transcripts
were enriched in stumpy cells, matching expectation for the life cycle stage primed for transmission to
the insect vector.
In T. brucei transcript levels do not necessarily correspond to protein levels, as much regulation of
gene expression occurs post-transcriptionally through binding of regulators to (predominantly) the
3′UTR of a particular gene, with consequences for transcript stability and translational efficiency [65].
Proteomic analyses are therefore required to compare the protein composition of various T. brucei life
cycle forms. RNA-binding proteins, cell surface proteins and proteins involved in mitochondrial and
glycosomal energy metabolism have been found to vary in abundance between cultured bloodstream
and procyclic form T. brucei [66,67]. Such studies often used SILAC (stable isotope labelling by
amino acids in culture) and this methodology has been extended to analysis of protein abundance
in slender, stumpy and procyclic cells of the pleomorphic cell line T. brucei AnTat 1.1 [68]. Here, it
was observed that mitochondrial proteins were more abundant in stumpy and procyclic cells than
in slender cells, with many protein abundance changes already being evident between the slender
and stumpy stages. It is important to note that the increase in abundance of mitochondrial proteins
in procyclic cells observed in this study was of a greater magnitude than in a previous study [67]
that did not use a pleomorphic strain of T. brucei. This emphasises the need to use pleomorphic
strains, competent to complete the life cycle, to fully characterise the features of different life cycle
forms. Further insight into the timings of protein abundance changes during the T. brucei life cycle has
been obtained by following changes in protein abundance and phosphorylation before and after the
point of commitment to differentiation from bloodstream stumpy cells to procyclic cells [51]. Just 3 h
following stimulation of differentiation with cis-aconitate, proteins associated with the procyclic form
cell surface and developmental changes in metabolism were upregulated. Additionally, a change in
the phosphorylation status of eukaryotic initiation factors was detected consistent with reinitiation
of protein synthesis early in differentiation [62]. Likewise, also using the synchronous differentiation
of stumpy cells, Dejung et al. found proteins indicative of a changing cell surface and metabolism
increased in abundance 2 h following induction of differentiation [69]. Moreover, some proteins
enriched in procyclic cells, such as PAD2 and TbPIP39 were already more abundant in stumpy cells
relative to slender cells.
As a consequence of the extensive differences in the characteristics and developmental potential
of slender and stumpy cells of Trypanosoma brucei it is important to be able to identify these forms
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within a population of trypanosomes under study (Figure 2). For instance, in cases where variations
in gene expression over time or in different conditions are being reported in bloodstream parasites
it is essential to consider whether perceived differences may be a result of varying proportions of
differentiated cells, which may or may not be a consequence of the conditions under test. For example,
in the recent description of transcripts in T. brucei that show circadian control [70], a reporter cell line
with GFP expression under the control of the PAD1 3′UTR was used to confirm that the majority of the
trypanosome cultures under study were slender (GFP-negative). This confirmed that variations in the
transcript abundances observed were not contributed by variations in the proportion of stumpy cells.
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Figure 2. Characteristics of a stumpy cell. A number of assays can be used to test the ro ortion of
cells in a T. brucei bloodstream form population that are slender or stumpy. (1) Firstly, stumpy cells are
clearly morphologically distinct from slender cells. The representative cells shown have been labelled
with the DNA stain DAPI (white) to highlight the position of the nucleus and kinetoplast in each
case. (2) Secondly, stumpy cells express the PAD1 protein on their surface [27]. PAD1 positive cells
can be identified using the PAD1 antibody by immunofluorescence microscopy or Western blotting.
PAD-based reporter assays have also been established for enzymatic or cytological quantitation.
(3) Stumpy cells also have a more elaborated mitochondrion than slender cells [23] and this can be
detected by incubating the cells with mitotracker dye [24] b fore fixing and visualising th cells with
a fluoresc nce microscope. (4) During the cel cycle, T. brucei cells first segregate their replicated
mitochondrial g nome (kinetoplast, K) and then their nucleu (N) prior to cytokin sis to ge erate two
daughter cells [71]. Stumpy cells are arrested in G1/G0 of the cell cycle and have 1 kinetoplast and
1 nucleus (1K1N) [37]. Thus, differentiation to a stumpy population is accompanied by an accumulation
of 1K1N cells, and this can be detected by staining with an appropriate DNA dye (e.g., DAPI) and KN
scoring by immunofluorescence microscopy or flow cytometry (a completely stumpy population will
have a single dominant peak corresponding to G1/G0). (5) Finally, stumpy cells, unlike slender cells,
are able to differentiate synchronously to procyclic cells in culture [41], when differentiation is triggered
by incubating cells at 27 ◦C in SDM-79 medium containing 6 mM cis-aconitate. Differentiation to
procyclic cells is indicated by expression of EP procyclin [72] and can be detected using an EP procyclin
antibody and flow cytometry. Maximal expression of EP procyclin is detectable 3 h after exposure of
stumpy cells to cis-aconitate [51].
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3. Tools to Understand Life Cycle Development
In parallel to the extensive characterisation of slender and stumpy form parasites, there has
also been significant progress in understanding of the mechanisms regulating differentiation from
slender to stumpy cells. This has been assisted by tools and technologies that enable dissection of the
underlying processes.
Early differentiation work focused on the anti-proliferative properties of the repurposed
anti-cancer drug DL-α-difluoromethylornithine (DFMO), a specific irreversible inhibitor of the
enzyme responsible for catalysing the first reaction in the polyamine biosynthesis pathway, ornithine
decarboxylase (ODC) [73,74]. Exposure of mammalian cells to DFMO causes a rapid depletion of
intracellular levels of the polyamines spermidine and putrescine resulting in the cessation of cellular
proliferation, though largely in the absence of cell death [73,75]. Furthermore, many studies have
attested to the importance of the role that polyamines, in particular spermidine and putrescine, play in
the stimulation and regulation of mammalian cell differentiation (reviewed in [76]). Based on these
observations, early studies sought to explore the possibility that polyamine depletion upon DFMO
treatment could function to regulate T. brucei slender to stumpy differentiation, and, moreover whether
DFMO induced differentiation events, and the subsequent morphological and physiological changes,
were relevant to those seen in natural pleomorphic populations [77]. After treatment with DFMO,
monomorphic T. brucei strains, grown either in vitro or in vivo, quickly became deficient in polyamines
and stopped proliferating with no apparent cytotoxic effect [77–80]. In addition, monomorphic slender
cells transformed morphologically to a smaller rounder cell form with a shortened flagellum, suggestive
of a stumpy-like form [77]. While Bacchi et al. [78] were unable to isolate true stumpy cells from DFMO
treated animals, possibly due to clearance by the immune system, de Gee et al. [79] demonstrated
enhanced activity of NAD diaphorase in monomorphic cells isolated from infections following DFMO
treatment, suggesting activation of the mitochondrion in preparation for transmission to the tsetse fly.
Giffin et al. [77] reported similar morphological and physiological changes in response to DFMO when
culturing monomorphic strains in vitro. However, though the DFMO-treated cells appeared to have
increased mitochondrial activity and some stumpy characteristics, they were not able to efficiently
transform to procyclic cells in SDM79 medium [77,80]. Moreover, treatment with an exogenous source
of putrescine was shown to relieve the effects of DFMO treatment allowing cells to successfully re-enter
proliferation [77] contrasting with the irreversible and uniform cellular quiescence in G0/G1 [37] of
stumpy cells. The DFMO response therefore does not fully resemble physiological differentiation.
A similar non-physiological response which superficially resembled the natural slender to
stumpy differentiation process was observed by Penketh et al. [81] following repeated exposure
of cells to low concentrations of the methylating agent 1,2-bis(methylsulfonyl)-1-methylhydrazine.
Monomorphic cells treated either in vitro or in vivo morphologically resembled stumpy cells within
48 h, expressed elevated mitochondrial activity and were able to establish stable procyclic cultures
when transferred to Cunningham’s Medium. Despite the eventual accumulation of G0/G1 arrested
cells upon exposure, analogous to events in natural populations, this was not before progression
through a transitional stage that appeared defective in cytokinesis. Specifically, large numbers
of multinucleated cells (3–4 nuclei/cell) predominated before semi-synchronous progression to a
G0/G1 arrested population [6,81] indicating 1,2-bis(methylsulfonyl)-1-methlhydrazine was not useful
as a tool for physiologically-relevant differentiation studies. Cell cycle arrest and morphological
transformation to stumpy-like cells has also been observed in vivo following treatment with a small
molecule inhibitor of Clan CA cysteine proteinases, carbobenzoxy-phenylalanyl-alanine-diazomethyl
ketone (Z-Phe-Ala-CHN2) [82]. Though pleomorphic cells arrested in their growth (without an
accumulation of multinucleated cells) and displayed stumpy-like morphology following treatment
with the inhibitor, this was accompanied by a significant enlargement of both the lysosome and the
parasite, and decreased protein degradation, suggesting that the Z-Phe-Ala-CHN2 response is also
non-physiological [82].
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An important breakthrough came in 1997 when Vassella et al. described a novel experimental
tool which provided insight into the mechanism of stumpy differentiation [6]. Prior to this study, it
had been speculated that the slender to stumpy differentiation was triggered by the accumulation of
an exogenous growth inhibitor upon reaching a critical cell density, as demonstrated by the ability
of plasma from infected animals to inhibit cell proliferation in vitro [83] and the observation that
pleomorphic cells would arrest and differentiate to stumpy cells above particular cell densities [6,84].
An elegant series of experiments utilising conditioned medium prepared from bloodstream form
cultures at high density demonstrated that parasite density alone induced differentiation, thus
excluding cellular programming, depletion of essential nutrients or cell-to-cell contact as possible
initiators of the slender to stumpy transition. Pleomorphic cells cultured in the presence of
conditioned medium rapidly and uniformly arrested in G0/G1 (without accumulating aberrant
cell cycle configurations), morphologically became stumpy, and exhibited NADH diaphorase activity.
The effect of the conditioned medium was attributed to a soluble, heat stable, ≤500 Da molecule
termed SIF, the identity of which remains elusive [6]. Significantly, SIF-induced differentiated cells
were capable of synchronous differentiation to procyclic cells upon a temperature drop and exposure
to cis-aconitate, further demonstrating the physiological relevance of the differentiation events induced
by exposure to conditioned medium. Interestingly, laboratory-adapted monomorphic cells, incapable
of natural differentiation to stumpy cells in vivo, were less responsive to SIF; however conditioned
medium prepared from these cell lines was equally as effective as that from pleomorphic cells at
inducing cell cycle arrest and differentiation to stumpy cells in differentiation-competent recipients.
As such, this suggested that monomorphic cells produce functional SIF, but are in some form defective
in either receiving or transducing the SIF signal through a competent pathway [6].
The SIF response pathway represented the next piece in the puzzle. Intracellular levels of
cyclic 3′, 5′-adenosine monophosphate (cAMP) had provoked interest following the demonstration
of its presence and fluctuation during the course of in vivo slender to stumpy differentiation [85,86].
During infection, the intracellular cAMP content of parasites was shown to increase over three-fold as
the parasitaemia reached peak density, then returned to basal levels as stumpy cells accumulated [87].
Hypothesizing a model whereby the density-dependent production of SIF triggers the cAMP signalling
pathway to induce differentiation, Vassella et al. [6] exposed pleomorphic cultured cells to the
membrane-permeable cAMP analogue 8-(4-chlorophenylthio)-cAMP (8-pCPTcAMP). This generated
rapid cell cycle arrest, induction of stumpy morphology, activation of the mitochondrion and
accumulation of cells in G0/G1 with near identical kinetics to that of SIF-induced differentiation, with
no cytotoxicity. Moreover, intracellular cAMP levels were shown to increase 2–3-fold upon incubation
of cells with SIF [6]. Thus, the cAMP signalling pathway was considered a conceivable inducer of
slender to stumpy differentiation which responded to the density-mediated accumulation of SIF.
The capacity for 8-pCPTcAMP to induce differentiation events in monomorphic cell lines [88] provided
further support for the differentiation promoting properties of cAMP, and led to the hypothesis that
8-pCPTcAMP could be a useful tool to identify the genes involved in slender to stumpy differentiation.
Whilst there was little doubt that 8-pCPTcAMP could trigger differentiation events analogous
to those initiated by SIF, the perception that cAMP played an important role in the induction and
regulation of slender to stumpy differentiation remained in question, as no direct cAMP-dependent
effector proteins were annotated in the genome [89]. Ultimately, Laxman et al. [89] were able to
demonstrate that the events observed by Vassella et al. [6] were attributable to the potent activity
of the hydrolysis product of 8-pCPTcAMP (8-pCPT-2′-O-Me-5′-AMP) rather than 8-pCPTcAMP
itself. This was achieved by comparing the effects of membrane-permeable and hydrolysis-resistant
8-pCPTcAMP analogues on cell proliferation [89]. Significantly, this demonstrated that cAMP itself was
not involved in the induction of the slender to stumpy differentiation pathway, but rather a hydrolysis
product of it, such as AMP.
For differentiation or infection studies to be physiologically relevant, pleomorphic cell culture
and genetic manipulation methods required development and optimization. The first report of
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successful continuous in vitro culture of a pleomorphic cell line came in 1979 when Brun et al. used a
mammalian feeder cell layer consisting of a rabbit fibroblast-like cell line grown in modified MEM
and supplemented with rabbit serum [90]. Today, the standard method of pleomorphic cell culture
involves maintenance of cells densities < 1 × 106 cells/mL [91] for minimal periods of time in HMI9,
a medium based on Iscoves modified DMEM medium supplemented with bathocuproinedisulphonic
acid, L-cysteine, hypoxanthine, 2-mercaptoethanol, pyruvate, thymidine and foetal bovine serum [92].
For many pleomorphic cell lines the provision of methyl cellulose also assists prolonged culture [84].
Building on the progress in establishing protocols for efficient procyclic [93] and monomorphic [94,95]
transfection, MacGregor et al. demonstrated the usefulness of Amaxa Nucleofector technology
when applied to pleomorphic cell transfection [91]. Shown to increase the transfection efficiency of
monomorphic cells 1000-fold [95], this technology increased the transfection efficiency of pleomorphic
AnTat 1.1 90:13 cells [26] to 10−7–10−6 thus permitting routine genetic manipulation of cells capable of
a full life cycle progression.
With advances in the repertoire of genetic experimental tools available to study T. brucei, for
example the discovery of an active RNAi pathway [96], improved transfection efficiencies [95,97]
and the publication of the Tritryp T. brucei genome in 2005 [98], it became possible to perform high
throughput gene function analyses. In particular, Alsford et al. described a novel, high resolution
experimental approach termed RNA Interference Target Sequencing (RITseq) which would allow for
genome-wide analysis of fitness upon induction of RNAi-mediated gene knockdown [36]. An inducible
RNAi library, providing around five-fold T. brucei genome coverage [99] was targeted to a unique
tagged rRNA locus [97] with an inducible meganuclease cleavage site [36,94]. Cell growth under
RNAi-induction led to a loss of representation of target sequences within the remaining proliferating
population when RNAi-mediated gene knockdown conferred a fitness deficit. Reads from Illumina
sequencing of PCR-amplified RNAi cassette insert DNA could be mapped back to the genome,
identifying “cold spots” representative of areas of the genome which were essential for growth in the
surveyed assay conditions [36]. Since its description, RITseq has proven to be a phenomenally effective
tool in both functional analyses and drug discovery settings. Essential genes for various life cycle stages
and events, mechanisms of antitrypanosomal drug action and resistance, and mitochondrial proteins
essential for normal cell growth and division have all been identified using RITseq [36,100,101].
4. Molecular Components of the Slender to Stumpy Regulatory Pathway
By combining RITseq technology and selection using differentiation-inducing 8-pCPTcAMP/AMP,
Mony et al. were able to identify and validate many intracellular components of the signalling pathway
driving stumpy formation [102]. Monomorphic T. brucei populations, transfected with the RNAi
library, were exposed to membrane permeable 8-pCPTcAMP/AMP and grown in vitro with or without
RNAi induction. Uninduced populations became non-proliferative and underwent cell death in
response to 8-pCPTcAMP/AMP. In contrast, the induced population parasites, where components
of the signalling pathway had been silenced by RNAi, continued to proliferate in the presence of the
differentiation signals. Thereafter, RNAi insert DNA was amplified from the 8-pCPTcAMP/AMP
resistant, differentiation defective populations and subjected to Ion Torrent deep sequencing, with
reads aligned to the trypanosome genome. The screen identified an extensive cascade of molecules,
together assembling a complex signalling pathway driving slender to stumpy differentiation. Groups of
identified genes formed distinct tiers of a signalling pathway, from protein kinase and phosphatase
signal transducers (e.g., YAK (Tb927.10.15020) and PP1 (Tb927.4.3620/30/40)) to RNA-binding effector
molecules such as RBP7 (Tb927.10.12100) [102,103]. Critically, whilst the RNAi library cell line used
in the screen to identify pathway components was monomorphic, the physiological relevance of the
genes identified by Mony et al. [102] was verified in pleomorphic cell lines. Thus, nine of the genes
were tested for sensitivity to SIF upon RNAi induction in vivo. In contrast to the AnTat 1.1 90:13
parental cell line which underwent cell cycle arrest and differentiation to transmission competent
stumpy cells, all but two of the induced RNAi lines generated in the study (ADSL (Tb927.9.7550)
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and ADSS (Tb927.11.3650)) showed increased resistance to SIF, revealed by a delayed or defective
differentiation phenotype. Thus, induced cell populations retained slender morphology, showed
reduced expression of the stumpy marker PAD1, did not enrich in G0/G1 arrested cells and lacked
an elaborated mitochondrion. Mony et al. [102] were therefore able to utilize a potent combination of
classic and newly developed technologies and tools to provide information on the genes required to
differentiate from proliferative long slender bloodstream forms to transmission competent quiescent
stumpy cells [103].
In addition to the aforementioned signal transducers YAK (Tb927.10.15020) and PP1
(Tb927.4.3620/30/40), the α2 subunit of AMPK (Tb927.3.4560) was identified by Mony et al. [102] in
the genome-wide RNAi screen. AMPK, a fundamental regulator of energy homeostasis, is activated in
response to alterations in the cellular AMP/ATP ratio. In mammalian cells grown in stress conditions,
a drop in ATP levels, and a corresponding rise in cellular AMP, triggers AMPK to phosphorylate
downstream targets, thus coordinating ATP generating and consuming processes to bring about
energy balance [103,104]. Mammalian AMPK is an inhibitor of the evolutionarily conserved protein
kinase target of rapamycin (mTOR), a regulator of cell growth, cell cycle, stress response and energy
balance [105,106]. Characterisation of the trypanosome TOR like proteins, TbTOR1 and TbTOR2,
revealed central functions, analogous to those of their mammalian counterparts, in protein synthesis
and cell growth (TbTOR1) and in maintaining cytokinesis (TbTOR2) [107]. Interestingly, however,
the structurally and functionally distinct TbTOR4 paralog was described to function as part of
a larger complex with TbLST8, MVP and TbArmtor (TbTORC4) to negatively regulate slender to
stumpy differentiation [106], thus forming a potential link to the identified AMPK in the Mony et al.
screen [102]. Upon induction of TbTOR4 RNAi in monomorphic cultures, cells exhibited hallmarks
of slender to stumpy differentiation: morphological change; an irreversible accumulation of cells
in G0/G1; mitochondrial elaboration; and the ability to establish procyclic cultures upon treatment
with cis-aconitate. Upon TbTOR4 knockdown, mRNA and protein analysis showed a subtle increase
in PAD1 expression, though not to the same extent as wild type pleomorphic cells undergoing
differentiation. Treatment with 8-pCPTAMP also led to a rapid decrease in TbTOR4 protein levels,
supporting the argument against a cAMP dependent pathway and establishing a model where high
levels of cellular AMP could activate AMPK which in turn would inhibit the negative regulator TbTOR4,
thus allowing the developmental switch from slender to stumpy cells to occur [106]. In addition to
TbTOR4, further negative regulators of slender to stumpy form differentiation have been identified,
such as MAPK5 [108] and a zinc-finger kinase, ZFK [109]. Though a ZFK null mutant demonstrated
reduced growth and increased expression of stumpy markers in vitro the phenotype was not observed
in vivo [109]. A MAPK5 null mutant, however, prematurely differentiated to stumpy cells in vivo [108].
More recently, Saldivia et al. [15] have suggested that AMPKα1, and not the AMPKα2 that was
identified in the Mony et al. screen [102], is associated with the positive regulation of stumpy form
development. In vitro phosphorylation analysis using an α-phospho-Thr172 antibody showed that
AMPKα1 phosphorylation was significantly upregulated upon treatment with 8-pCPTAMP, whereas
AMPKα2 phosphorylation levels were unaffected. In addition, upon AMPKα1 phosphorylation, levels
of stumpy specific transcripts, such as PAD1 and PAD2, were increased and TbTOR4 protein levels
were decreased. Moreover, during in vivo analysis with a pleomorphic strain, AMPKα1 was not found
be phosphorylated in slender form parasites, whereas its phosphorylation was detected early during
differentiation and this was maintained until the population had fully differentiated to stumpy cells.
A role for AMPKα1 was further supported by the observation that its phosphorylation was abrogated
upon treatment of mice with the AMPK inhibitor compound C, although the specificity of the inhibitor
activity was not proven.
5. Future Considerations
With improved molecular descriptions of T. brucei stumpy cells and tools to disrupt or stimulate
the differentiation step from slender to stumpy cells, we are now well placed to investigate the signals
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contributing to T. brucei differentiation in the mammalian host. The availability of cell lines able to
report on stumpy formation through PAD1 3′UTR control [28], for example encoding a GFP reporter
with a nuclear localisation signal and PAD1 3′UTR [34,58,59], or the use of a PAD1 antibody [27]
enables the quantification of stumpy cells in a population. Furthermore, knowledge of the signalling
components regulating differentiation [102] has made possible the generation of signal-blind cell lines
which do not respond to the quorum-sensing signal. Together such tools could help to identify signals
triggering slender to stumpy differentiation through the quorum-sensing signalling pathway, perhaps
guiding the identification of the elusive SIF. Regardless of this, the progress made in understanding
the molecular control of differentiation in the mammalian bloodstream has revealed new research
opportunities and therapeutic implications, as detailed below.
Firstly, understanding of the mechanisms coordinating slender to stumpy differentiation could be
employed to force parasites to differentiate prematurely allowing clearance by the host. For example,
a differentiation-mediated therapeutic option has already been considered, with compounds capable of
inducing slender to stumpy [33] or slender to procyclic form differentiation [110] having been identified
in screens using either PAD1 or procyclin 3′UTR regulated reporter cell lines. With identification
of the core molecular regulators of differentiation, more targeted therapeutic approaches may now
be explored.
Secondly, given the differential sensitivity of slender and stumpy bloodstream parasites to immune
attack [55], mild-acid and proteases [14], it is possible that the different biology of stumpy cells makes
them more resistant to trypanocidal drugs than slender cells. In the case of Plasmodium falciparum,
resistance to the antimalarial drug artemisinin was attributed to persister populations generated by
the cell cycle arrest of ring stage parasites, with such parasites able to resume development following
removal of drug pressure [111]. The difference in the case of T. brucei is that stumpy cells are irreversibly
arrested in their cell cycle and cannot resume development in the bloodstream. Therefore, a drug
treatment that killed slender cells but left surviving stumpy cells would not result in recrudescence
of the parasites although transmission might still be possible in the short term. Nevertheless, the
metabolism or drug sensitivity of monomorphic cells may not fully reflect the sensitivity or resistance
of pleomorphic parasites and new therapeutics should be screened on field-relevant strains rather than
laboratory adapted lines.
Thirdly, it will be necessary to understand the development from slender to stumpy cells in
the context of different mammalian hosts. For example, although stumpy cells were observed to
be dominant in T. brucei chronic infection of mice [8], the differentiation status of T. brucei during
chronic cattle infection, where parasitaemias are often lower, has not been carefully quantitated.
Hence, fly infectivity in acute and chronic stages of infections [112] should be correlated with the
proportion and abundance of slender and stumpy cells to determine the relevance of development for
the epidemiology of animal African trypanosomiasis (AAT).
Finally, Trypanosoma brucei bloodstream forms can invade beyond the bloodstream and into tissues.
In late stages of infection parasites can be found within the brain parenchyma [113]. Recently, other
reservoirs of T. brucei have been described including the adipose tissue [34] and the skin [114,115].
Adipose tissue forms of T. brucei were shown to have up-regulated expression of genes involved in fatty
acid metabolism, indicating an adaptation to that tissue environment. Additionally, trypanosomes
inoculated into skin by tsetse fly bite were found to proliferate within the dermis with close interactions
between adipocytes and trypanosomes observed by scanning electron microscopy [115]. In both cases,
stumpy cells were identified in addition to those in the circulating bloodstream. Hence, trypanosomes
resident in the skin or adipose tissue may contribute to transmission in cases where parasitaemia is very
low, as can be the case in chronic infections of sylvatic reservoirs. A further consideration is that the
nature of different tissue compartments may affect the diffusion and accumulation of a quorum-sensing
signal involved in density-dependent differentiation. Thus, it remains to be determined whether
transmissible cells have migrated into the tissue following differentiation in the bloodstream or have
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undergone differentiation within the tissue. Likewise, the extent of flux between compartments
throughout the duration of the infection is currently unknown.
6. Conclusions
The development of T. brucei in the mammalian host is likely coordinated through a complex
network of interactions with quorum-sensing mediated density control modulated by different host
environments whether this be different host species or different compartments within one host.
Moreover, in field settings, the chronic nature of African trypanosome infections often results in
co-infections between T. brucei and the other African trypanosome species, Trypanosoma congolense and
Trypanosoma vivax [116–118]. Thus, the presence of a competitor species of African trypanosome could
also contribute to the T. brucei differentiation dynamic in the field. We now have a more detailed picture
of the biology and molecular regulation of differentiation in the host bloodstream. Future research
will need to build on these discoveries and consider how they apply to the economically important
livestock infections and how they might impact on the zoonotic potential of human infective parasites
in reservoir hosts. The detailed dissection of the signals mediating trypanosome differentiation within
the mammalian host may be challenging, but will provide fascinating insight into the intricate biology
tying these parasites to their host, and potentially cohabiting species. This in turn may suggest
innovative interventions capable of combatting these persistent pathogens.
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